SCHEMBL6189224

SCHEMBL6189224

Cn1nnc(-c2ccccc2C=O)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.44
GRM5 P41594 2/20 0.41
XDH P47989 1/20 0.41
KCNN4 O15554 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
THRB P10828 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.37
TSHR P16473 1/20 0.37
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6188044 0.80 GRM5 (0.39) GRM5XDHKCNN4MEN1LMNA
SCHEMBL31336779 0.80 TP53 (0.38) PDK2LMNAALDH1A1NPC1RAB9A
SCHEMBL5504840 0.76 NPC1 (0.41) PDK2GRM5NPC1RAB9ANFKB1
SCHEMBL13846109 0.75 PDK2 (0.48) PDK2GRM5MEN1LMNAKMT2A
SCHEMBL6155 0.75 POLB (0.39) GRM5XDHKCNN4MEN1LMNA
SCHEMBL9033772 0.74 AGTR1 (0.41) GRM5XDHKCNN4MEN1LMNA
SCHEMBL2647877 0.74 PDK2 (0.50) PDK2GRM5MEN1LMNAKMT2A
SCHEMBL28496060 0.72 LMNA (0.55) GRM5XDHKCNN4MEN1LMNA
SCHEMBL30165767 0.72 LMNA (0.55) GRM5XDHKCNN4MEN1LMNA
SCHEMBL13846219 0.71 NPSR1 (0.58) PDK2GRM5KCNN4LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929553-B1 PYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2005-03-16 EP disclosed
US-6251911-B1 Pyrimidine derivatives and processes for the preparation thereof NOVARTIS AG (CH) 2001-06-26 US disclosed
EP-0929553-A1 PYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1999-07-21 EP disclosed
WO-1998014450-A1 PYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 1998-04-09 WO disclosed